Innovative Showcase: Japan Pavilion at Arab Health 2024

JETRO organized the Japan Pavilion at the 49th edition of Arab Health, held from 29th January to 1st February 2024, at the Dubai World Trade Centre. The event attracted over 130,000 visitors, with 3,627 participating companies from 78 countries.

This year, the Japan Pavilion was set-up by JETRO for the 13th time, with record-breaking number of 29 exhibiting Japanese companies. In addition, the first-ever Digital Health Start-up area was introduced, with 11 out of the 29 companies exhibiting.

Japan is the world’s second largest medical device market, and its products are famous for “Japanese Quality”, such as accuracy, preciseness, and convenience, ensuring safety and comfort for patients. All participating Japanese companies are keen on expanding globally, with significant potential to contribute to the medical requirements in the Middle East and across the globe.

One of the exhibitors, AMI Inc., offering a “Super StethoScope”, a medical device that enables individuals to screen and monitor cardiovascular diseases non-invasively; participated in a pitch event hosted by PureHealth, a major medical conglomerate in the UAE. AMI received a number of inquiries from various distributors showing a high interest in their technology. On the other hand, several participating companies of Japan Pavilion were able to meet potential counterparts in the region during the exhibition.

After the event, JETRO provided an opportunity to the participating companies of Japan Pavilion and Japanese medical device-related companies in the UAE to visit a multispecialty hospital in Abu Dhabi with state-of-the-art amenities and world-class service standard facilities, the Cleveland Clinic Abu Dhabi.

CCAD is part of M42 group, a global tech-enabled healthcare company in Abu Dhabi, and a unique extension of US-based Cleveland Clinic’s model of care.

During the visit, CCAD, M42 group, and ADRO (Abu Dhabi Residents Office) gave a presentation on Abu Dhabi’s healthcare, investment opportunities, and living environment, followed by a hospital tour at CCAD facilities.